PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING MIR-324 and TUT4/7 EXPRESSION MODULATORS
AssigneesSeoul National University R&Db Foundation, Institute for Basic Science
InventorsV. Narry KIM, Haedong KIM, Jimi KIM
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating cancer, comprising miR-324 and TUT4/7 expression modulators, wherein the pharmaceutical composition of the present invention can prevent cell division and hinder cancer development by inhibiting the function of TUT4/7, and can increase the amount of miR-324-5p and suppress the function of miR-324-3p.1, and therefore can be effectively used for prevention, treatment, or diagnosis of cancer.
Claims13
Method of treating cancer, comprising administering to a subject in need thereof a pharmaceutical composition for preventing or treating cancer, the composition comprising a microRNA(miRNA) which is comprising i) a miR-324-5p or an isoform thereof, and ii) a miR-324-3p or an isoform thereof:
- wherein the i) miR-324-5p comprising the nucleotide sequences of SEQ ID NO:
- 47 at the 5′ end, and a total of 20 to 24 nucleotide sequences;
- wherein the ii) miR-324-3p is,
- a) the first base from the 5′ end may be C or G;
- b) the first base from the 5′ end is complementary to the 20th base from the 5′ end of the miR-324-5p;
- and
- c) the 20th base from the 5′ end may be A, U, or C.
A method of treating cancer, comprising:
- administering to a subject in need thereof a pharmaceutical composition for preventing or treating cancer, the composition comprising at least one selected from the group consisting of:
- a nucleic acid composed of the nucleotide sequence of SEQ ID NO:
- 4;
- and
- a small interfering RNA (siRNA) comprising at least one nucleotide sequence selected from the group consisting of SEQ ID NOS:
- 5 to 20.
A method of diagnosing cancer, comprising measuring a level of:
- i) at least one miRNA selected from the group consisting of miR-324-5p and miR-324-3p.1;
- or
- ii) at least one gene mRNA or protein thereof selected from the group consisting of TUT4 (terminal uridylyl transferases 4) and TUT7 (terminal uridylyl transferases 7).
Dependencies are inferred from the claim text.